MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

Abstract

BACKGROUND Rectal cancer accounts for approximately one third of all colorectal cancers (CRC), which belong among leading causes of cancer deaths worldwide. Standard treatment for locally advanced rectal cancer (cT3/4 and/or cN+) includes neoadjuvant chemoradiotherapy with fluoropyrimidines (capecitabine or 5-fluorouracil) followed by radical surgical… (More)
DOI: 10.1186/1748-717X-7-195

Topics

3 Figures and Tables

Cite this paper

@inproceedings{Svoboda2012MicroRNAEP, title={MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients}, author={Marek Svoboda and Jiri Sana and Pavel Fabian and Ilona Koc{\'a}kov{\'a} and Jana Gombosova and Jana Nekvindov{\'a} and Lenka Radov{\'a} and Rostislav Vyzula and Manu N Capoor}, booktitle={Radiation oncology}, year={2012} }